Those Specialty Drugs Likely Cost More Than Your Household Income

A new report says a year's worth of specialty drugs now outpaces the U.S. median household income. Elsewhere, using brand-name drugs over generic equivalents doesn't often boost patient satisfaction. And the price of hepatitis C drugs may be holding back the eradication of the disease and playing a role as Medicaid denies nearly half of requests for the treatments.